Effects of glepaglutide, a novel long-acting glucagon-like peptide-2 analogue, on markers of liver status in patients with short bowel syndrome: findings from a randomised phase 2 trial.
EBioMedicine（2019）
摘要
Zealand Pharma.
更多查看译文
关键词
Short bowel syndrome,Transient elastography,Indocyanine green,Soluble CD163,Soluble mannose receptor
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要